Scientists have shown that disruption of the body’s internal clock system is involved in a range of diseases, from psychiatric to metabolic to cardiovascular.
In its early phase, encapsulation research was divided, with experts in different disciplines focused on different aspects of the science. JDRF created the Encapsulation Consortium in 2013, jump-starting the field by encouraging collaboration among its 25+ members and shaping a strategy to guide res...
JDRF showcases the remarkable people who benefit from JDRF-funded research while striving to accelerate the pace of research in Canada.
JDRF and the American Diabetes Association, in Collaboration with Multiple Diabetes Organizations Publish New Classification and Staging Approach for Presymptomatic Type 1. Diabetes Organizations Endorse Concept that Autoimmune Disease Begins Long Before Symptoms Occur and Progresses through Distinc...
The stationary bicycles are tuned, greased and ready for corporate Canada to start cycling in support of JDRF at the 2015 JDRF Ride for Diabetes Research (JDRF Ride). This fall, all across Canada various business sectors will trade in their suits for sweats as they go head-to-head in this unique sta...
A Canadian research team working on the development of an external artificial pancreas is receiving a grant of $2,509,367 USD from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the U.S. National Institutes of Health (NIH).
Innovative treatment for type 1 diabetes marks first step towards vision of regional network for islet cell isolation and transplant
JDRF-Supported Researchers Make Gains in Designing Islet Cell Encapsulation Materials for Use in Type 1 Diabetes Therapies
New study shows size and shape of encapsulation materials have an effect on islet cell survival
BD and Medtronic Collaborate to Introduce a New Infusion Set with BD FlowSmart Technology Designed to Improve Insulin Pump Therapy
BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Medtronic (NYSE: MDT) today announced a collaboration to introduce a new insulin pump infusion set with BD FlowSmart™ technology